These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 8974581)

  • 1. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-arrhythmic activity of quinuclidine derivatives].
    Svistov AS; Skorobogatov VI
    Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antiarrhythmic action of the synthetic acetylcholine analog EDIHYP in calcium chloride- and strophanthin-induced heart rhythm disorders].
    Abdikaliev NA; Kalvin'sh IIa; Meerson FZ
    Farmakol Toksikol; 1991; 54(6):25-8. PubMed ID: 1804687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The anti-arrhythmia properties of thymogen].
    Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
    Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The experimental anti-arrhythmia properties of the histamine H1 receptor blockader fencarol].
    Iakovlev GM; Skorobogatov VI; Svistov AS; Mironova MI
    Farmakol Toksikol; 1991; 54(5):25-7. PubMed ID: 1686869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a new calcium antagonist (Ro 11-1781) on the cardiac conduction system in man.
    Gmeiner R; Ng CK; Simma H; Gstöttner M
    Eur J Cardiol; 1979 Jan; 9(1):77-86. PubMed ID: 759190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea].
    Maĭmeskulova LA; Maslov LN; Lishmanov IuB; Krasnov EA
    Eksp Klin Farmakol; 1997; 60(1):38-9. PubMed ID: 9162281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative characteristics of the activity of lithium preparations and anti-arrhythmia agents in strophanthin, calcium chloride and barium chloride arrhythmias in an experiment].
    Galenko-Iaroshevskiĭ PA; Tikhonov AV
    Farmakol Toksikol; 1985; 48(2):64-8. PubMed ID: 3996574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmic action of preparations of the dihydropyridine series].
    Frol'kis VV; Frol'kis RA; Dubur GIa; Golovchenko SF; Shevchuk VG
    Farmakol Toksikol; 1983; 46(6):20-4. PubMed ID: 6653752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anti-arrhythmic activity of agonists of the peripheral mu-opiate receptors].
    Maslov LN; Krylatov AV; Lishmanov IuB
    Eksp Klin Farmakol; 1999; 62(3):28-31. PubMed ID: 10439944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 17. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some aspects of the antiarrhythmic effect of glialin].
    Khisatmutdinova RIu; Baschenko NZh; Zarudiĭ FS; Gabdrakhmanova SF; Makara NS; Sapozhnikova TA
    Eksp Klin Farmakol; 2006; 69(3):26-8. PubMed ID: 16878494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism].
    Lishmanov IuB; Maslova LV; Maslov LN; Dan'shina EN
    Biull Eksp Biol Med; 1993 Aug; 116(8):175-6. PubMed ID: 7506072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.